Method for improving stability of latex suspension liquid
A technology of suspension and stability, applied in the application field of in vitro diagnostic kits, can solve problems such as long-term stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0016] Prepare latex-enhanced C-reactive protein reagent (CRP) reagent according to Table 1
[0017] Table 1
[0018] substance
concentration
MES solution
25mmol / L
Emulsion of latex particles cross-linked with CRP antibody
2.5g / L
EDTA.Na2
5mmol / L
BSA
10g / L
5g / L
PBS buffer pH=8.0
100mmol / L
[0019] Each component is mixed to obtain latex-enhanced C-reactive protein reagent (CRP) reagent solution;
[0020] Then add some non-ionic surfactants, such as Tween20, to the C-reactive protein reagent (CRP) reagent prepared above according to Table 2.
[0021] Table 2
[0022] Solution number
Protective agent
[0023] 1
no added
2
0.05% Tween 20
3
0.10% Tween 20
4
0.15% Tween 20
5
0.20% Tween 20
[0024] In Table 2, 0.05% Tween 20 means that the added weight of Tween 20 is 0.05% of the C-reactive prote...
Embodiment 2
[0031] Prepare rheumatoid factor reagent (RF) reagent solution as follows.
[0032] Table 4
[0033] substance
concentration
MES solution
25mmol / L
Emulsion of latex particles of cross-linked human IgG
2.5g / L
EDTA.Na2
5mmol / L
BSA
10g / L
5g / L
PBS buffer pH=8.0
100mmol / L
[0034] The components are mixed to obtain a rheumatoid factor reagent (RF) reagent solution.
[0035] Then add some sodium salicylate, a substance that can improve the charging state of the particle surface, to the above prepared rheumatoid factor (RF) reagent according to the following table.
[0036] table 5
[0037] serial number
Protective agent
1
no added
2
5mmol / L sodium salicylate
3
10mmol / L sodium salicylate
4
100mmol / L sodium salicylate
5
200mmol / L sodium salicylate
[0038] Store the rheumatoid factor reagent (RF) solutions numb...
Embodiment 3
[0044] Utilize the latex reagent preserved under the common solution condition prepared by the present invention to carry out the comparative study of pH, what use here is the CRP common latex reagent and the RF common latex reagent prepared in example 1 and example 2.
[0045] Table 7
[0046] C-reactive protein reagent (CRP) reagent
[0047] substance
concentration
MES solution
25mmol / L
Emulsion of latex particles cross-linked with CRP antibody
2.5g / L
EDTA.Na2
5mmol / L
BSA
10g / L
5g / L
PBS buffer pH=8.0
100mmol / L
[0048] Rheumatoid reagent (RF) reagent
[0049] substance
concentration
MES solution
25mmol / L
Emulsion of latex particles of cross-linked human IgG
2.5g / L
EDTA.Na2
5mmol / L
BSA
10g / L
sucrose
5g / L
PBS buffer pH=8.0
100mmol / L
[0050] The above solution obtained according to Table 7 was divi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com